Skip to content

The Efficacy of Low versus High Volume in Lumbar Transforaminal Epidural Steroid Injection, A Randomized controlled trial

The Efficacy of Low versus High Volume in Lumbar Transforaminal Epidural Steroid Injection, A Randomized controlled trial

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
TCTR
Registry ID
TCTR20200819004
Enrollment
62
Registered
2020-08-19
Start date
2020-10-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lumbosacral radicular pain lumbosacral radicular pain spinal stenosis herniated disc pulposus

Interventions

Triamcinolone acetate (40mg/ml) 1 ml 0.5% Bupivacaine 2 ml Normal saline 5 ml Total volume 8 ml ,Triamcinolone acetate (40mg/ml) 1 ml 0.5% Bupivacaine 2 ml Total volume 3 ml
Active Comparator Procedure/Surgery,Active Comparator Procedure/Surgery
group A,group B

Sponsors

Prince of Songkla university
Lead Sponsor
Prince of Songkla university
Collaborator

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Unilateral single-level lumbosacral radicular pain patient who not significant improvement with physical therapy or medication at least 6 weeks Age 18-65 years old

Exclusion criteria

Exclusion criteria: 1.Allergy to Steroid &#44; Local anesthetic agents or contrast media 2.History of epidural steroid injection within 3 months 3.History of lumbar spine surgery 4.History of coagulopathy or obligatory use of anticoagulant 5.History of uncontrolled diabetes mellitus 6.History of inflammatory joint disease (Rheumatoid arthritis / ankylosing spondylitis / SLE) 7.Significant neurodeficit(motor power < grade III) or cauda equina syndrome 8.Local skin/subcutaneous infection or systemic infection 9.Pregnancy 10.Tumor 11.Trauma

Design outcomes

Primary

MeasureTime frame
Pain reduction after transforaminal epidural steroid injection 2&#44;4&#44;12 weeks Visual analog scale,Pain reduction after transforaminal epidural steroid injection 2&#44;4&#44;12 weeks Visual analog scale,Pain reduction after transforaminal epidural steroid injection 2&#44;4&#44;12 weeks Visual analog scale,Pain reduction after transforaminal epidural steroid injection 2&#44;4&#44;12 weeks Visual analog scale

Secondary

MeasureTime frame
modified Oswestry disability questionnaire 2&#44;4&#44;12 weeks modified Oswestry disability score [Thai version],Change of analgesic intake frequency 2&#44;4&#44;12 weeks milligrams ,Adverse events 2&#44;4&#44;12 weeks percentages

Countries

Thailand

Contacts

Public ContactPawin Wanasitchaiwat

Department of Orthopedics&#44; Faculty of Medicine Prince of Songkla University

palmsko4ever@gmail.com0830920610

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026